Niihara International’s work and the underlying science behind L-glutamine therapy have been featured in leading journals and media outlets:
Clinical trial results on L-glutamine therapy
Research and public health impact
Reduction in sickle cell complications
Global health and digital infrastructure initiatives
Niihara International, Inc. Announces Launch of New
Below is a translation of a letter
For individuals or institutions interested in learning more about Niihara International’s corporate structure and investment-related disclosures, additional information is available through the company’s regulatory filings.
